BERLEX SUES FDA CLAIMING BIOGEN's AVONEX VIOLATES BETASERON ORPHAN EXCLUSIVITY; FILES FOR RESTRAINING ORDER INDICATING AVONEX APPROVAL IS IMMINENT

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".